Implementation of Stereotactic Ablative Radiotherapy for the Treatment of Oligometastatic Cancer in Canada

CADTH has conducted an Environmental Scan to support a health technology assessment project that regarded the use of stereotactic ablative radiotherapy (SABR) for the treatment of oligometastatic cancer. The scan provides an understanding of the current practice regarding the use of SABR in Canada, as well as the implementation considerations for expanding its use for the treatment of oligometastatic cancer.

The key objectives of this Environmental Scan are to:

• identify and describe how SABR technology is being accessed and used by Canadian jurisdictions
• identify and describe the systems that are in place to manage SABR treatment for patients with oligometastatic cancer, including training and resource allocation
• compare the application of SABR technology in treating localized disease versus oligometastatic disease in terms of the infrastructure required for delivery
• identify and describe the barriers and facilitators to the implementation of SABR treatment for patients with oligometastatic cancer.